Truist Financial Keeps Their Buy Rating on Kimbell Royalty Partners (KRP)
Truist Financial Reaffirms Their Hold Rating on BWX Technologies (BWXT)
Truist Financial Remains a Buy on Bristol-Myers Squibb (BMY)
Incyte (INCY) Receives a Hold From Truist Financial
Truist Financial Sticks to Its Hold Rating for Amgen (AMGN)
Truist Financial Downgrades Merck & Company (MRK) to a Hold
Truist Financial Gives a Buy Rating to GFL Environmental (GFL)
HSBC Upgrades Truist Financial(TFC.US) to Buy Rating, Raises Target Price to $50
Truist Financial Is Maintained at Equal-Weight by Barclays
Truist Finl Analyst Ratings
Truist Financial Issues a Buy Rating on Sonoco Products (SON)
Barclays Maintains Truist Financial(TFC.US) With Hold Rating, Raises Target Price to $51
Marinus (MRNS) Gets a Hold From Truist Financial
Enterprise Products Partners (EPD) Receives a Buy From Truist Financial
Truist Finl Analyst Ratings
Stephens & Co. Reiterates Overweight on Truist Finl, Maintains $54 Price Target
Wells Fargo Maintains Truist Financial(TFC.US) With Buy Rating, Maintains Target Price $52
Wells Fargo Keeps Their Buy Rating on Truist Financial (TFC)
Shake Shack (SHAK) Receives a Buy From Truist Financial
Truist Financial Remains a Buy on Sabra Healthcare REIT (SBRA)